Fibromyalgia. It’s time you know the truth.
Fibromyalgia is a chronic disorder marked by symptoms including pain, fatigue, sleep disturbances, depression, and thinking and memory problems. Known to impact an estimated six percent or more of the population, it isn’t age, gender or ethnically specific. Without objective diagnostic tools FM sufferers have historically been subject to speculation and skepticism by friends, family and even the medical community.
Current FM treatment options include anticonvulsants, opioids, and antidepressants, which may help temporarily manage symptoms, but can’t treat the underlying cause. Several of these drugs carry “Black Box Warnings” regarding their potentially dangerous side effects.
The FM/a® Test around the world. We now offer testing of patients from the U.S., Canada, Europe, Turkey, Mexico, Central and South America, the Caribbean, Hong Kong, Australia and New Zealand.
The FM/a® Test, is the first and currently only objective, FDA-compliant blood test for fibromyalgia. It’s simple and requires less than an ounce of blood. With a few exceptions, the FM/a® Test is available in most every state and is now available in Canada, Europe, Turkey, Mexico, Central and South America, the Caribbean, Hong Kong, Australia and New Zealand. Your blood specimen will be analyzed at our California laboratory.
Bruce S. Gillis, M.D., M.P.H., is the Founder of EpicGenetics, a biomedical company dedicated to developing conclusive diagnostic tests for complex medical conditions. Under Dr. Gillis’ leadership, EpicGenetics has developed the first diagnostic test for fibromyalgia – The FM/a® Test.
Recognized for his exceptional research in multiple peer-reviewed manuscripts, Dr. Gillis has established himself as a physician, an entrepreneur and as a medical researcher.
Dr. Gillis for the last several years has maintained active research programs at both the University of Illinois College of Medicine at Chicago and the Harvard School of Public Health.
Dr. Gillis received his undergraduate and medical education at the University of Illinois at Chicago and concurrently also attended the Harvard School of Public Health where he received a Masters in Public Health degree. In the span of seven years, Dr. Gillis completed medical school, his Harvard Masters program, two medical residencies and two medical fellowships.
He has had faculty positions both at the University of California, Los Angeles and the University of Illinois College of Medicine at Chicago.